Trials / Completed
CompletedNCT05429177
A First-in-Human Study of QY101 Ointment in Adult Subjects
This is a Phase I, Randomized, Double-blind, Vehicle-controlled Study of QY101 Ointment in Chinese Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 77 (actual)
- Sponsor
- E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a phase I, randomized, double-blind, vehicle-controlled，single and multiple ascending dose study to assess the safety, tolerability, and pharmacokinetics of QY101 ointment in Chinese healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | QY101 ointment or vehicle | QY101 ointment or vehicl topical applied to skin |
Timeline
- Start date
- 2022-06-08
- Primary completion
- 2023-06-21
- Completion
- 2023-06-21
- First posted
- 2022-06-23
- Last updated
- 2023-09-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05429177. Inclusion in this directory is not an endorsement.